Danielle Antin-ozerkis MD in New Haven, Connecticut

Home Connecticut New Haven

Danielle Antin-ozerkis MD has Pulmonary Disease as her primary medical specialty. Their primary office is: 789 Howard Ave in New Haven, Connecticut.

They're a part of the: Yale University medical group which has around 2,243 members. You can call their office at 203-688-2471 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Perelman School Of Med At The University Of Pennsylvania and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Danielle Elyse Antin-ozerkis MD Office Phone and Directions

Danielle Antin-ozerkis MD
Yale University
789 Howard Ave
New Haven, Connecticut 06519
203-688-2471

Patient Ratings
Please rate your experience with Danielle Antin-ozerkis MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 203-688-2471

Enter a starting address:

Healthcare Info for Danielle Antin-ozerkis MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Perelman School Of Med At The University Of Pennsylvania
Graduation Year: 1999
The Primary Medical Specialty for Danielle Antin-ozerkis MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 3173520988
NPI #: 1336234947
NPI Created On: 10/03/2006
NPI Last Updated Listed as: 01/28/2014
Primary Taxonomy Code: 207RC0200X
License Number:
044401
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Harvard Pilgrim Health Care Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Measurement and graphic recording of total and timed exhaled air capacity
Test for exercise-induced lung stress
Determination of lung volumes using gas dilution or washout
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes
Critical care delivery critically ill or injured patient
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $618

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician.

Record ID:: 822294871

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0143-60

Payments Total: $618

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician.

Record ID:: 822297439

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0143-60

Payments Total: $266

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician.

Record ID:: 822297613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0143-60

Payments Total: $272

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Transfer of value reported under this transaction represents publication support services and does not reflect any actual monetary transfer of value to the physician.

Record ID:: 822297759

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: OFEV

Open Associated Drug #1: 0597-0143-60